AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimwin-M1 Tablet ER

Prescription Icon
Prescription Required

Marketer

Healthkind Labs Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimwin-M1 Tablet ER

Diabetam-Duo ER tablets are categorized as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication regulates blood glucose levels. Diabetam-Duo ER should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial; discontinuation without medical supervision can elevate blood glucose, risking kidney complications, vision loss, neuropathy, and limb loss. Remember, this is part of a comprehensive program encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect; learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them. Consistent meals and carrying fast-acting glucose (e.g., sugary foods, fruit juice) are vital. Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your physician of any heart history before commencing treatment; pregnancy or breastfeeding requires prior medical consultation. Regular blood glucose monitoring, along with blood cell and liver function tests, may be recommended by your doctor.

Uses of Glimwin-M1 Tablet ER

Managing Type 2 Diabetes

Major Benefits of Glimwin-M1 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimwin-M1 Tablet ER. Ingest the tablet whole; do not crush, chew, or break it. Consume this medication with food.

Common Side effects of Glimwin-M1 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimwin-M1 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimwin-M1 Tablet ER whole; avoid chewing, crushing, or breaking it. It should be administered with food.

How Glimwin-M1 Tablet ER works:

Glimwin-M1 ER tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimwin-M1 Tablet ER is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimwin-M1 Tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

Extended-release Glimwin-M1 tablets are contraindicated for breastfeeding mothers due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Exercise caution when administering Glimwin-M1 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glimwin-M1 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimwin-M1 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver disease, initiate Glimwin-M1 Tablet ER therapy at a reduced dosage; its use is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glimwin-M1 Tablet ER :

Should you forget a Glimwin-M1 Tablet ER dose, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed one and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Glimwin-M1 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimwin-M1 Tablet ER

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimwin-M1 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimwin-M1 Tablet ER and seek immediate medical attention.
Glimwin-M1 ER tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 DM.
Glimwin-M1 ER tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimwin-M1 Tablet ER use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Glimwin-M1 ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimwin-M1 Tablet ER and alcohol is unsafe. Alcohol can exacerbate Glimwin-M1's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimwin-M1 Tablet ER
33
MRP 40
18% off